A "Bridge-Building" Glycan Scaffold Mimicking Microbial Invasion for In Situ Endothelialization

© 2021 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 33(2021), 42 vom: 05. Okt., Seite e2103490
1. Verfasser: Mu, Ruoyu (VerfasserIn)
Weitere Verfasser: Zhang, Yuhan, Yan, Lingli, Liao, Zhencheng, Yang, Yushun, Su, Huanxing, Dong, Lei, Wang, Chunming
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article angiogenesis blood vessels carbohydrates cell adhesion natural biomaterials Biocompatible Materials Galectin 1 Mannans (1-6)-alpha-glucomannan 36W3E5TAMG
Beschreibung
Zusammenfassung:© 2021 Wiley-VCH GmbH.
The globally high prevalence of peripheral artery diseases poses a pressing need for biomaterials grafts to rebuild vasculature. When implanted, they should promote endothelial cells (ECs) adhesion both profoundly and selectively-but the latter expectation remains unfulfilled. Here, this work is inspired by fungi that invade blood vessels via the "bridge" of galectins that, secreted by ECs, can simultaneously bind carbohydrates on fungal surface and integrin receptors on ECs. A glucomannan decanoate (GMDE) substrate mimicking fungal carbohydrates that highly and preferentially supports ECs adhesion while rejecting several other cell types is designed. Electrospun GMDE scaffolds efficiently sequester endogenous galectin-1-which bridges ECs to the scaffolds as it functions in fungal invasions-and promote blood perfusion in a murine limb ischemic model. Meanwhile, the application of GMDE requires no exogenous pro-angiogenic agents and causes no organ toxicity or adverse inflammation in mice, highlighting its high safety of potential translation. This glycan material, uniquely mimicking a microbial action and harnessing a secreted protein as a "bridge," represents an effective, safe, and different strategy for ischemic vascular therapy
Beschreibung:Date Completed 07.02.2022
Date Revised 07.02.2022
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202103490